Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
114 studies found for:    Empagliflozin
Show Display Options
Rank Status Study
1 Recruiting Effect of Empagliflozin on Liver Fat Content in Patients With Type 2 Diabetes
Condition: Non Alcoholic Fatty Liver Disease
Intervention: Drug: Empagliflozin
2 Completed Effect of Empagliflozin on Macrovascular and Microvascular Circulation and on Endothelium Function
Condition: Diabetes Mellitus Type 2
Interventions: Drug: Empagliflozin;   Drug: Placebo
3 Recruiting Effects of Empagliflozin on Left Ventricular Diastolic Function Compared to Usual Care in Type 2 Diabetics
Conditions: Diabetes Mellitus, Type 2;   Diastolic Dysfunction
Interventions: Drug: Empagliflozin;   Drug: Placebo
4 Recruiting Effects of Empagliflozin + Linagliptin vs Metformin + Insulin Glargine on Renal and Vascular Changes in Type 2 Diabetes
Condition: Diabetes Mellitus Type 2
Interventions: Drug: Empagliflozin and Linagliptin;   Drug: Metformin and Insulin sc
5 Not yet recruiting Empagliflozin vs Metformin in PCOS
Condition: Polycystic Ovary Syndrome
Interventions: Drug: Empagliflozin;   Drug: Metformin
6 Not yet recruiting Effects of Empagliflozin on Cardiac Structure in Patients With Type 2 Diabetes
Conditions: Diabetes;   Cardiovascular Disease
Interventions: Drug: Empagliflozin;   Drug: Placebo
7 Completed Effects of Linagliptin in Addition to Empagliflozin on Islet Cell Physiology
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Linagliptin;   Other: Placebo;   Drug: Empagliflozin
8 Recruiting Effects of Empagliflozin on Liver Fat Content, Energy Metabolism and Body Composition in Patients With Type 2 Diabetes
Conditions: Type 2 Diabetes;   Non-alcoholic Fatty Liver Disease
Interventions: Drug: Empagliflozin;   Drug: Placebo
9 Recruiting Empagliflozin and ACEi Effects on Hyperfiltration in Type 1 Diabetes (BETWEEN Study)
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: Empagliflozin;   Drug: Placebo (matching empagliflozin);   Drug: ramipril
10 Not yet recruiting The Effect of Empagliflozin on NAFLD in Asian Patients With Type 2 Diabetes
Conditions: Type2 Diabetes;   NAFLD
Intervention: Drug: Empagliflozin
11 Completed Empa/Lina FDC Food Effect Study (Japan)
Condition: Healthy
Intervention: Drug: empagliflozin/linagliptin FDC
12 Completed
Has Results
Demonstrate Bioequivalence of Two 12.5 mg Empagliflozin/500 mg Metformin Fixed Dose Combination Tablets With Free Combination of Empagliflozin 25 mg and Metformin 1000 mg in Healthy Male and Female Volunteers Under Fed Conditions
Condition: Healthy
Interventions: Drug: Empagliflozin;   Drug: Metformin
13 Not yet recruiting Double Blind Placebo Study of JARDIANCE® (Empagliflozin) in Prehypertensives Type II Diabetics
Conditions: Hypertension;   Type II Diabetes
Interventions: Drug: empagliflozin;   Drug: Metformin
14 Completed Bioequivalence of a Fixed Dose Combination Tablet of Empagliflozin/Metformin Extended Release Compared With Mono Compound Tablets in Healthy Male and Female
Condition: Healthy
Interventions: Drug: metformin;   Drug: empagliflozin/metformin;   Drug: empagliflozin
15 Completed Bioequivalence of a Fixed Dose Combination Tablet of Empagliflozin/Metformin Extended Release Compared With Mono Compound Tablets in Healthy Subjects
Condition: Healthy
Interventions: Drug: metformin;   Drug: empagliflozin/metformin;   Drug: empagliflozin
16 Recruiting JARDIANCE Regulartory Post Marketing Surveillance in Korean Type 2 Diabetes Mellitus
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: JARDIANCE 10mg;   Drug: JARDIANCE 25mg
17 Completed Bioequivalence of a Fixed Dose Combination Tablet of Empagliflozin/Linagliptin Compared With the Free Combination of Empagliflozin Tablet and Linagliptin Tablet in Healthy Male and Female Subjects
Condition: Healthy
Interventions: Drug: Empagliflozin;   Drug: Linagliptin
18 Not yet recruiting Evaluate the Drug-drugs Interaction Between Lobeglitazone and Empagliflozin
Condition: Diabetes Mellitus, Type II
Interventions: Drug: Empagliflozin 25mg;   Drug: Lobeglitazone 0.5mg;   Drug: Empagliflozin 25mg/Lobeglitazone 0.5mg
19 Recruiting The Effect Effect of Empagliflozin on Oxidative Stress in Patients With Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Empagliflozin;   Drug: Placebo
20 Not yet recruiting SGLT-2 Inhibitor Empagliflozin Effects on Appetite and Weight Regulation.
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Empagliflozin;   Behavioral: Diet;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.